news aktuell GmbHnews aktuell GmbH

Beating cancer with Harm Reduction

Del

Bruxelles - The Independent European Vape Alliance (IEVA) welcomes and supports the “EU Beating Cancer Plan” presented today by the European Commission. The plan is extremely important in order to significantly reduce the number of cancer-related deaths. However, the new EU strategy neglects an important instrument for public health: Harm Reduction.

Almost one third of cancer cases in Europe are caused by smoking:
Tobacco consumption continues to be the leading cause of preventable cancer, with 27% of all cancers attributed to tobacco use. By eliminating tobacco use, nine out every ten cases of lung cancer could be avoided.[1]

It is therefore more important than ever to use all means at hand to minimize smoking rates. Tobacco harm reduction is rated as a very good opportunity to significantly reduce the number of smokers. That is why it has to be included in an impactful EU Beating Cancer plan:

When it comes to smoking cessation, the EU Commission is once again concentrating on the 'quit or die' approach instead of creating a realistic addiction policy.", says Prof Heino Stöver from the German Institute for Addiction Research at the Frankfurt University of Applied Sciences. And further: “Great Britain, New Zealand and Canada are putting the e- Cigarette as a main tool in the fight against tobacco use and have been shown to be very successful.[2]

Cancer potencies: 0.5% of the risk of smoking

In embracing harm reduction the UK shows a better and more effective strategy to decrease the number of smokers. With broad education on harm-reducing alternatives, British health policy has drastically reduced the smoking rate within a few years. In 2011, 20 percent of the British still smoked, in 2019 it was around 14 percent.[3]

In 2018, the government agency Public Health England (PHE) published a report with data on e-cigarettes. According to PHE, vapers have a 99.5 percent lower risk of cancer than smokers. Overall, PHE estimates that e-cigarettes are at least 95 percent less harmful than tobacco cigarettes.[4]

Dustin Dahlmann, Chairman of IEVA: “We welcome the EU Beating Cancer Plan. The strategy needs to consider all means available to reduce the burden of cancer related risks: It is of utmost importance that preventive measures are flanked by tobacco harm reduction. Otherwise, millions of smokers might miss the opportunity to tremendously reduce their risk of cancer.

[1] EU Beating Cancer Plan, 2021. Link

[2] Prof Heino Stöver, Press release, February 03, 2021. Link

[3] Adult smoking habits in the UK: 2019. Link

[4] “Evidence review of e-cigarettes and heated tobacco products”, Public Health England 2018. Link

Kontakter

Independent European Vape Alliance (IEVA)
President: Dustin Dahlmann
Press coordinator: Philip Drögemüller
Phone: +32 (2) 791 7759
E-Mail: p.droegemueller@eurovape.eu
Web: www.eurovape.eu

Lenker

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

IEVA - Independent European Vape Alliance

The Independent European Vape Alliance (IEVA) is the only pan-European association aimed at uniting national associations, companies, manufacturers and wholesalers in the vaping industry and providing them with responsible representation at the European level.

IEVA’s founding principle is to contribute to harm reduction and public health. E-cigarettes have a significant positive impact and should be recognized as a harm reduction tool because vaping is not smoking.  

Følg saker fra news aktuell GmbH

Registrer deg med din epostadresse under for å få de nyeste sakene fra news aktuell GmbH på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra news aktuell GmbH

European Association of E-Pharmacies (EAEP): EAEP as a Driving Force and Think Tank: European Association of Online Pharmacies Repositions Itself23.2.2021 09:00:00 CETPress release

(Brussels/Berlin): – The leading association of European online pharmacies has a new board team, a new name and a new external image: Walter Hess, Head Germany in the Group Management of the Zur Rose Group and CEO of DocMorris N.V., is now president of the association and Stefan Feltens, CEO SHOP APOTHEKE EUROPE, is vice president and secretary general. With the new leadership duo, the association of online pharmacies will shape the European healthcare sector’s digital transformation in a future-oriented way. A key goal is to further expand the practical patient benefits of online pharmacies in the implementation of future e-health concepts. Vladimir Finsterle, CEO and founder of Pearls Health Cyber s.r.o., and Gianni De Gaspari, CEO and co-founder of the online pharmacy Viata, complete the board. By changing its name from EAMSP (European Association of Mail Service Pharmacies) to EAEP (European Association of E-Pharmacies), the association underlines its key role in Europe’s increasin

Fireworks for Enzo Ferrari! Ferrari is cult - from now on also art! I see red! Buongiorno sono Enzo19.2.2021 09:01:03 CETPressemelding

London/Modena/Maranello Fireworks for Enzo Ferrari! Ferrari is cult - from now on also art! I see red! Buongiorno sono Enzo. Today I turned 123 years old. My message: The 250 GT-O 1962 is a sculpture - not just on wheels. Heiko Saxo - the car artist literally struck! From the original parts of a 250 GT 12 sculptures were created in Weert Netherlands. Another work of art rears up around the sculptures. The 4.50 m tall horse made of steel with the legendary components of the Testarossa, Daytona Spyder from 1969 and 275 GTB from 1965. Heiko Saxo discovered his sculptural elements hidden in a back hall in Modena, the birthplace of Enzo Ferrari and also in southern Italy. Dusty and covered, Saxo recognized the silhouettes of the unaffordable supercars. The passion of Heiko Saxo, who transforms the motorsport world into works of art in shapes, colors and tones. As a declaration of love to the master of construction and motorsport, Heiko Saxo dedicates his red collection. The Saxo Bank of Art

Grünenthal successfully extends its term loan bank facilities12.2.2021 13:46:41 CETPressemelding

Aachen, Germany, 12 February 2021 – Grünenthal has announced the successful extension of its existing €535 million term loan bank facilities. This amendment was conducted in the broader context of the company’s acquisition of the European rights (excluding Spain and the UK) to the lipid-lowering medication CRESTOR™ completed in February 2021. The term loan maturities are now aligned with Grünenthal’s Revolving Credit Facility maturity, which further extends its debt maturity profile. More than 60 percent of Grünenthal’s debt facilities now mature in 2024 or later. “By extending the maturity of our financing, we have gained additional flexibility to further fund our growth strategy,” says Fabian Raschke, Chief Financial Officer of Grünenthal. „We will continue to explore opportunities to further support our organic growth with targeted acquisitions, that fit our EBITDA and cash flows accretive acquisition strategy.“ Grünenthal’s capital structure has enabled it to enter into a series of

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom